• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白70减少α-突触核蛋白的聚集和毒性。

Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity.

作者信息

Klucken Jochen, Shin Youngah, Masliah Eliezer, Hyman Bradley T, McLean Pamela J

机构信息

Alzheimer's Disease Research Laboratory, Harvard Medical School, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.

出版信息

J Biol Chem. 2004 Jun 11;279(24):25497-502. doi: 10.1074/jbc.M400255200. Epub 2004 Mar 25.

DOI:10.1074/jbc.M400255200
PMID:15044495
Abstract

Aggregation and cytotoxicity of misfolded alpha-synuclein is postulated to be crucial in the disease process of neurodegenerative disorders such as Parkinson's disease and DLB (dementia with Lewy bodies). In this study, we detected misfolded and aggregated alpha-synuclein in a Triton X-100 insoluble fraction as well as a high molecular weight product by gel electrophoresis of temporal neocortex from DLB patients but not from controls. We also found similar Triton X-100 insoluble forms of alpha-synuclein in an alpha-synuclein transgenic mouse model and in an in vitro model of alpha-synuclein aggregation. Introducing the molecular chaperone Hsp70 into the in vivo model by breeding alpha-synuclein transgenic mice with Hsp70-overexpressing mice led to a significant reduction in both the high molecular weight and detergent-insoluble alpha-synuclein species. Concomitantly, we found that Hsp70 overexpression in vitro similarly reduced detergent-insoluble alpha-synuclein species and protected cells from alpha-synuclein-induced cellular toxicity. Taken together, these data demonstrate that the molecular chaperone Hsp70 can reduce the amount of misfolded, aggregated alpha-synuclein species in vivo and in vitro and protect it from alpha-synuclein-dependent toxicity.

摘要

错误折叠的α-突触核蛋白的聚集和细胞毒性被认为在帕金森病和路易体痴呆(DLB)等神经退行性疾病的发病过程中至关重要。在本研究中,我们在DLB患者而非对照者的颞叶新皮质的Triton X-100不溶性部分以及通过凝胶电泳检测到的高分子量产物中检测到错误折叠和聚集的α-突触核蛋白。我们还在α-突触核蛋白转基因小鼠模型和α-突触核蛋白聚集的体外模型中发现了类似的Triton X-100不溶性形式的α-突触核蛋白。通过将α-突触核蛋白转基因小鼠与过表达Hsp70的小鼠杂交,将分子伴侣Hsp70引入体内模型,导致高分子量和去污剂不溶性α-突触核蛋白种类均显著减少。同时,我们发现体外过表达Hsp70同样减少了去污剂不溶性α-突触核蛋白种类,并保护细胞免受α-突触核蛋白诱导的细胞毒性。综上所述,这些数据表明分子伴侣Hsp70可以在体内和体外减少错误折叠、聚集的α-突触核蛋白种类的数量,并保护其免受α-突触核蛋白依赖性毒性。

相似文献

1
Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity.热休克蛋白70减少α-突触核蛋白的聚集和毒性。
J Biol Chem. 2004 Jun 11;279(24):25497-502. doi: 10.1074/jbc.M400255200. Epub 2004 Mar 25.
2
A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity.单个氨基酸取代区分了热休克蛋白70(Hsp70)对α-突触核蛋白降解和毒性的依赖性作用。
Biochem Biophys Res Commun. 2004 Dec 3;325(1):367-73. doi: 10.1016/j.bbrc.2004.10.037.
3
Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.路易体痴呆中不溶性α-突触核蛋白的临床与生化相关性
Acta Neuropathol. 2006 Feb;111(2):101-8. doi: 10.1007/s00401-005-0027-7. Epub 2006 Feb 16.
4
Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro.格尔德霉素可诱导热休克蛋白70(Hsp70)生成,并在体外防止α-突触核蛋白聚集及毒性产生。
Biochem Biophys Res Commun. 2004 Aug 27;321(3):665-9. doi: 10.1016/j.bbrc.2004.07.021.
5
Alpha-synuclein and chaperones in dementia with Lewy bodies.路易体痴呆中的α-突触核蛋白与伴侣蛋白
J Neuropathol Exp Neurol. 2005 Dec;64(12):1058-66. doi: 10.1097/01.jnen.0000190063.90440.69.
6
The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease.α-突触核蛋白在多系统萎缩中的溶解度与路易体痴呆和帕金森病中的溶解度不同。
J Neurochem. 2001 Jan;76(1):87-96. doi: 10.1046/j.1471-4159.2001.00021.x.
7
Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species.热休克蛋白70通过优先结合前纤维状物质来抑制α-突触核蛋白原纤维的形成。
J Biol Chem. 2005 Apr 15;280(15):14733-40. doi: 10.1074/jbc.M413024200. Epub 2005 Jan 25.
8
Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity.人α-突触核蛋白的酪氨酸到半胱氨酸修饰增强了蛋白质聚集和细胞毒性。
J Biol Chem. 2004 Mar 12;279(11):10128-35. doi: 10.1074/jbc.M307563200. Epub 2003 Dec 29.
9
FLZ Attenuates α-Synuclein-Induced Neurotoxicity by Activating Heat Shock Protein 70.氟氯西林通过激活热休克蛋白70减轻α-突触核蛋白诱导的神经毒性。
Mol Neurobiol. 2017 Jan;54(1):349-361. doi: 10.1007/s12035-015-9572-9. Epub 2016 Jan 7.
10
TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation.扭转蛋白A和热休克蛋白作为分子伴侣:抑制α-突触核蛋白聚集。
J Neurochem. 2002 Nov;83(4):846-54. doi: 10.1046/j.1471-4159.2002.01190.x.

引用本文的文献

1
Chaperone-Mediated Responses and Mitochondrial-Endoplasmic Reticulum Coupling: Emerging Insight into Alzheimer's Disease.伴侣介导的反应与线粒体-内质网偶联:对阿尔茨海默病的新见解
Cells. 2025 Jul 31;14(15):1179. doi: 10.3390/cells14151179.
2
Metabolic Syndrome and Parkinson's Disease: Two Villains Join Forces.代谢综合征与帕金森病:两大“反派”联手
Brain Sci. 2025 Jun 30;15(7):706. doi: 10.3390/brainsci15070706.
3
α-Synuclein-Assembled Synaptic Vesicle Pools at the Presynaptic Terminal: A Study of α-Synuclein Function Using a Novel Mouse Model.
突触前末端的α-突触核蛋白组装的突触小泡池:使用新型小鼠模型对α-突触核蛋白功能的研究
Acta Histochem Cytochem. 2025 Jun 24;58(3):107-114. doi: 10.1267/ahc.25-00017. Epub 2025 Jun 18.
4
α-Synuclein-Assembled Synaptic Vesicle Pools at the Presynaptic Terminal: A Study of α-Synuclein Function Using a Novel Mouse Model.突触前末端的α-突触核蛋白组装的突触小泡池:使用新型小鼠模型对α-突触核蛋白功能的研究
Acta Histochem Cytochem. 2025 Jun 24;58(3):107-114. doi: 10.1267/ahc.25-00017. Epub 2025 Jun 18.
5
Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson's Disease.神经退行性疾病中的α-突触核蛋白病理生理学:聚焦帕金森病分子机制与治疗进展的综述
Cell Mol Neurobiol. 2025 Mar 26;45(1):30. doi: 10.1007/s10571-025-01544-2.
6
Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson's disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation.溶血磷脂酰胆碱促进帕金森病中α-突触核蛋白聚集:破坏葡糖脑苷脂酶糖基化和溶酶体α-突触核蛋白降解。
NPJ Parkinsons Dis. 2025 Mar 15;11(1):47. doi: 10.1038/s41531-025-00902-7.
7
Novel Poly-Arginine Peptide R18D Reduces α-Synuclein Aggregation and Uptake of α-Synuclein Seeds in Cortical Neurons.新型聚精氨酸肽R18D可减少皮质神经元中α-突触核蛋白的聚集及α-突触核蛋白种子的摄取。
Biomedicines. 2025 Jan 7;13(1):122. doi: 10.3390/biomedicines13010122.
8
α-Synuclein in Parkinson's Disease: From Bench to Bedside.帕金森病中的α-突触核蛋白:从实验台到病床边
Med Res Rev. 2025 May;45(3):909-946. doi: 10.1002/med.22091. Epub 2024 Dec 20.
9
Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation.虽已破碎但未被击败:通过降解降低淀粉样蛋白致病性的挑战。
J Adv Res. 2025 Apr;70:45-62. doi: 10.1016/j.jare.2024.04.018. Epub 2024 Apr 19.
10
Genetic modifiers of synucleinopathies-lessons from experimental models.突触核蛋白病的基因修饰因子——来自实验模型的经验教训
Oxf Open Neurosci. 2023 Mar 9;2:kvad001. doi: 10.1093/oons/kvad001. eCollection 2023.